| IDYA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the IDYA market cap history going back to 5/23/2019:
Also see: IDYA Shares Outstanding History and IDYA YTD Return |
IDYA Market Cap History — IDEAYA Biosciences Capitalization Over Time
As of 5/1/2026 IDEAYA Biosciences has a market cap of 2.48 billion. Investors often follow the IDYA market cap history to compare the size of the company over time.
This page shows IDYA market capitalization trends over time, with 29 market cap datapoints presented, dating back to 5/23/2019.
| IDYA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IDYA Historical Market Cap: +41.90% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IDYA Stock Price Chart |
| About IDEAYA Biosciences Inc |
| IDEAYA Biosciences, Inc. is a precision medicine oncology company. Co. is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates are darovasertib (IDE196), IDE397, IDE161 and GSK101 (Pol Theta Helicase). IDE196, a small molecule protein kinase C (PKC), inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397, is its small molecule methionine adenosyltransferase 2a (MAT2A), inhibitor. IDE161, is its small molecule poly (ADP-ribose) glycohydrolase (PARG), inhibitor. We show 29 historical shares outstanding datapoints in our IDYA shares outstanding history coverage, used to compute IDYA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IDYA market cap history over the course of time is important for investors interested in comparing IDYA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IDYA versus a peer is one thing; comparing IDYA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IDYA can fluctuate over the course of history. With this page we aim to empower investors researching IDYA by allowing them to research the IDYA market cap history. |
| IDYA Current Stock Quote |
Quotes delayed 20 minutes  Free IDYA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| IDYA Share Performance |
| Market Cap Peers |
| IDEAYA Biosciences (IDYA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IGAP Market Cap History IGMS Market Cap History IIN Market Cap History IKNA Market Cap History IKT Market Cap History ILMN Market Cap History IMA Market Cap History IMAC Market Cap History IMDX Market Cap History IMDZ Market Cap History More Healthcare companies » |
IDYA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
